Adrenal insufficiency masquerading as sepsis in a patient with tetraparesis: a case report.
Several endocrine changes have been reported in patients with tetraplegia after spinal cord injury (SCI). These changes should be considered when prescribing medications that influence the endocrine pathways. Megestrol acetate has gained acceptance as a way to promote weight gain in cachectic patients without significant adverse effects. We present a case of a 51-year-old man with C5-C6 tetraparesis who was only 67% of his ideal body weight and was placed on megestrol acetate 5 months before admission for a urologic procedure. Postoperatively, the patient had severe hypotension and tachycardia that was interpreted as a septic or cardiac event. Further workup revealed subnormal levels of 8AM cortisol. An adrenocorticotrophic hormone stimulation test demonstrated results consistent with adrenal suppression. Hydrocortisone supplementation was started, and 6 months later cortisol levels were within normal limits. Cachexia, hypotension, and mild tachycardia are not uncommon in patients with SCI. When severe hypotension and tachycardia are seen in patients with tetraplegia, the diagnosis of adrenal insufficiency should be considered.
Lee
L W
LW
Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD 21239, USA.
Glenn
M B
MB
D000309:Adrenal Insufficiency / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy; D003937:Diagnosis, Differential; D006801:Humans; D006854:Hydrocortisone / Q000097:blood* / Q000627:therapeutic use; D007669:Kidney Calculi / Q000601:surgery; D008297:Male; D019290:Megestrol Acetate / Q000009:adverse effects; D008875:Middle Aged; D011183:Postoperative Complications; D011782:Quadriplegia / Q000150:complications*; D018805:Sepsis / Q000175:diagnosis*
D019290:Megestrol Acetate; D006854:Hydrocortisone